This company develops an integrated, AI-driven multiomics diagnostic platform utilizing a single-swab liquid biopsy assay. The technology combines genetic profiling and phenotyping to rapidly detect early-stage head-and-neck cancer in a point-of-care setting. Their focus is on providing accurate, accessible diagnostics to enable timely, personalized oncology treatment.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional methods for disease detection often rely on complex, time-consuming antibody-antigen tests conducted in centralized laboratories. This can lead to delays in diagnosis and treatment, particularly for diseases like cancer, where early detection is critical for improved patient outcomes. The need for specialized equipment and trained personnel further limits accessibility to advanced diagnostics, especially in point-of-care settings.
Solution
InnoTech Precision Medicine is developing a portable diagnostic device that enables rapid and accurate disease detection directly from liquid biopsies at the point of care. The device utilizes synthetic molecular biosensors to simultaneously detect multiple classes of macromolecules, including proteins and nucleic acids, from a single specimen. This multimodal detection approach enhances diagnostic accuracy and enables early detection of complex diseases, such as head and neck cancer. The platform aims to deliver high-performance diagnostics that are user-friendly and accessible, facilitating timely and effective treatment decisions.
Target Audience
The primary target audience includes healthcare providers, clinical researchers, and diagnostic companies seeking rapid, accurate, and accessible diagnostic solutions for early disease detection.
Features
- Portable diagnostic device for point-of-care disease detection
- Multimodal detection of proteins and nucleic acids from liquid biopsies
- Synthetic molecular biosensors for biomarker identification
- High-performance diagnostic solutions with rapid turnaround time
- User-friendly interface for ease of operation
- Focus on early detection of complex diseases, including head and neck cancer